SENSEX
NIFTY
GOLD
USD/INR

Weather

image 13    C

National News

News

National / The Economic Times

details

Eli Lilly cuts Zepbound price to widen access for obesity drug

Eli Lilly has reduced the cost of its popular obesity drug Zepbound for American patients. This move aims to make the treatment more accessible as demand for weight-loss medications skyrockets. Patients can now access Zepbound at lower prices through Lilly's online platform. This initiative follows similar price adjustments for other formulations of the drug.

1 Dec 2025 9:37 pm